首页 > 最新文献

Przeglad lekarski最新文献

英文 中文
Child’s dignity in suffering and death. 孩子在苦难和死亡中的尊严。
Pub Date : 2017-01-01
Grażyna Cepuch, Agnieszka Kruszecka-Krówka

The magnitude of unfair, absurd,pointless suffering we cannot acceptor understand makes it a phenomenonwhich defies human logic - especiallywhen it concerns children. The sourceof suffering of a dying child is pain,fear, failure to satisfy the basic humanneeds and concern about the parents.It is also heightened by medical procedures,including treatments aimedat preventing the unavoidable death.Such actions, resulting from the fearof death and a lack of acceptance ofdeath as the end of life burdened withsuffering, pose a risk to the child’s fundamentalrights and violate the sourceof human freedom - one’s inalienabledignity.Our priority should be to unconditionallyrespect the children’s rightspostulated by Korczak, to ensurethat while providing holistic care fora dying child, their dignity is alwaysconsidered the greatest good.

我们无法接受和理解的不公平、荒谬和毫无意义的痛苦之大,使其成为一种违背人类逻辑的现象——尤其是当它涉及到儿童时。临终儿童痛苦的根源是痛苦、恐惧、基本需求得不到满足以及对父母的担忧。医疗程序,包括旨在防止不可避免的死亡的治疗,也加剧了这种情况。这种行为源于对死亡的恐惧和不接受死亡是背负痛苦的生命的终结,对儿童的基本权利构成威胁,并侵犯了人类自由的源泉——一个人不可剥夺的尊严。我们的首要任务应该是无条件地尊重Korczak所规定的儿童权利,以确保在为垂死儿童提供全面照顾的同时,他们的尊严始终被认为是最大的利益。
{"title":"Child’s dignity in suffering and death.","authors":"Grażyna Cepuch,&nbsp;Agnieszka Kruszecka-Krówka","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The magnitude of unfair, absurd,\u0000pointless suffering we cannot accept\u0000or understand makes it a phenomenon\u0000which defies human logic - especially\u0000when it concerns children. The source\u0000of suffering of a dying child is pain,\u0000fear, failure to satisfy the basic human\u0000needs and concern about the parents.\u0000It is also heightened by medical procedures,\u0000including treatments aimed\u0000at preventing the unavoidable death.\u0000Such actions, resulting from the fear\u0000of death and a lack of acceptance of\u0000death as the end of life burdened with\u0000suffering, pose a risk to the child’s fundamental\u0000rights and violate the source\u0000of human freedom - one’s inalienable\u0000dignity.\u0000Our priority should be to unconditionally\u0000respect the children’s rights\u0000postulated by Korczak, to ensure\u0000that while providing holistic care for\u0000a dying child, their dignity is always\u0000considered the greatest good.</p>","PeriodicalId":21148,"journal":{"name":"Przeglad lekarski","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36042809","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Thyroid and aging: the present state of art]. [甲状腺与衰老:目前的研究现状]。
Pub Date : 2017-01-01
Robert Krysiak, Karolina Kowalcze, Agnieszka Kędzia, Bogusław Okopień

Aging is associated with importantchanges in thyroid hormone secretion,metabolism, and action. Itremains unclear, however, whetheraltered activity of the hypothamic-pituitary-thyroid axis represents physiologicchanges in thyroid function orwhether they are secondary to thyroiddysfunction. The prevalence ofthyroid disorders increases with age,but because some thyroid-associatedsymptoms are similar to symptomsof the aging process, these disordersare relatively rarely diagnosed. On theother hand, because of the possiblepresence of chronic, non-thyroidalillnesses or pharmacotherapy, diagnosisof thyroid disorders in olderpopulations is often much more challengingthan in young people. Progressmade in better understandingof thyroid disorders in older peoplehas thrown a new light on the managementof patients with these disorders,the clinical picture of which isoften atypical. Therefore, physiciansneed a high index of suspicion to detectthyroid dysfunction in an olderperson with multiple comorbiditiesand chronic polypharmacy. The purposeof this article is to review thepresent state of knowledge on theage-related changes in hypothalamicpituitary-thyroid axis activity and todiscuss the clinical course, diagnosisand treatment of thyroid disorders inthe elderly.

衰老与甲状腺激素分泌、代谢和作用的重要变化有关。然而,尚不清楚的是,下丘脑-垂体-甲状腺轴活性的改变是否代表甲状腺功能的生理改变,还是继发于甲状腺功能障碍。甲状腺疾病的患病率随着年龄的增长而增加,但由于一些甲状腺相关症状与衰老过程的症状相似,这些疾病相对很少被诊断出来。另一方面,由于可能存在慢性、非甲状腺疾病或药物治疗,老年人甲状腺疾病的诊断往往比年轻人更具挑战性。更好地了解老年人甲状腺疾病的进展为这些疾病患者的管理带来了新的曙光,这些疾病的临床表现通常是非典型的。因此,医生需要高度的怀疑指数来检测患有多种合并症和慢性多种药物的老年人的甲状腺功能障碍。本文旨在综述与年龄相关的下丘脑-垂体-甲状腺轴活动变化的研究现状,并对老年人甲状腺疾病的临床病程、诊断和治疗进行探讨。
{"title":"[Thyroid and aging: the present state of art].","authors":"Robert Krysiak,&nbsp;Karolina Kowalcze,&nbsp;Agnieszka Kędzia,&nbsp;Bogusław Okopień","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Aging is associated with important\u0000changes in thyroid hormone secretion,\u0000metabolism, and action. It\u0000remains unclear, however, whether\u0000altered activity of the hypothamic-pituitary-\u0000thyroid axis represents physiologic\u0000changes in thyroid function or\u0000whether they are secondary to thyroid\u0000dysfunction. The prevalence of\u0000thyroid disorders increases with age,\u0000but because some thyroid-associated\u0000symptoms are similar to symptoms\u0000of the aging process, these disorders\u0000are relatively rarely diagnosed. On the\u0000other hand, because of the possible\u0000presence of chronic, non-thyroidal\u0000illnesses or pharmacotherapy, diagnosis\u0000of thyroid disorders in older\u0000populations is often much more challenging\u0000than in young people. Progress\u0000made in better understanding\u0000of thyroid disorders in older people\u0000has thrown a new light on the management\u0000of patients with these disorders,\u0000the clinical picture of which is\u0000often atypical. Therefore, physicians\u0000need a high index of suspicion to detect\u0000thyroid dysfunction in an older\u0000person with multiple comorbidities\u0000and chronic polypharmacy. The purpose\u0000of this article is to review the\u0000present state of knowledge on the\u0000age-related changes in hypothalamicpituitary-\u0000thyroid axis activity and to\u0000discuss the clinical course, diagnosis\u0000and treatment of thyroid disorders in\u0000the elderly.</p>","PeriodicalId":21148,"journal":{"name":"Przeglad lekarski","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36044189","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Protein-bound uremic toxins - biological effects and impact on morbidity in patients with chronic kidney disease. 蛋白质结合尿毒症毒素-慢性肾病患者的生物学效应和对发病率的影响。
Pub Date : 2017-01-01
Małgorzata Gomółka, Stanisław Niemczyk

Cardiovascular complicationsare the main cause of increasedmortality in patients with chronic kidneydisease. Besides traditional riskfactors, accumulated uremic toxinscontribute to the accelerated atherosclerosis,which is accompanied bythe progression of chronic kidneydisease. Increased clearance of toxinswith low molecular weight doesnot significantly improve survival ofhemodialysis patients, and thereforethe role and influence of other toxins,including protein-bound solutes(PBS) is intensively investigated. Inour work, PBS is discussed on theexample of indoxyl sulphate and pcresolsulphate. These substancesare highly bound to proteins andremoved from the circulation duringdialysis to a small extent only.In our article, pathophysiological effects,the impact on the progressionof chronic kidney disease and thesurvival of patients were discussed.We also assessed available methodsof removing toxins from the system.

心血管并发症是慢性肾病患者死亡率增加的主要原因。除了传统的危险因素外,积累的尿毒症毒素有助于加速动脉粥样硬化,并伴随慢性肾病的进展。增加低分子量毒素的清除率并不能显著提高血液透析患者的生存,因此其他毒素,包括蛋白结合溶质(PBS)的作用和影响被深入研究。在我们的工作中,PBS以吲哚酚硫酸盐和预硫酸盐为例进行了讨论。这些物质与蛋白质高度结合,在透析过程中只在很小程度上从血液循环中去除。在我们的文章中,讨论了病理生理效应,对慢性肾脏疾病进展和患者生存的影响。我们还评估了从系统中清除毒素的可用方法。
{"title":"Protein-bound uremic toxins - biological effects and impact on morbidity in patients with chronic kidney disease.","authors":"Małgorzata Gomółka,&nbsp;Stanisław Niemczyk","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Cardiovascular complications\u0000are the main cause of increased\u0000mortality in patients with chronic kidney\u0000disease. Besides traditional risk\u0000factors, accumulated uremic toxins\u0000contribute to the accelerated atherosclerosis,\u0000which is accompanied by\u0000the progression of chronic kidney\u0000disease. Increased clearance of toxins\u0000with low molecular weight does\u0000not significantly improve survival of\u0000hemodialysis patients, and therefore\u0000the role and influence of other toxins,\u0000including protein-bound solutes\u0000(PBS) is intensively investigated. In\u0000our work, PBS is discussed on the\u0000example of indoxyl sulphate and pcresol\u0000sulphate. These substances\u0000are highly bound to proteins and\u0000removed from the circulation during\u0000dialysis to a small extent only.\u0000In our article, pathophysiological effects,\u0000the impact on the progression\u0000of chronic kidney disease and the\u0000survival of patients were discussed.\u0000We also assessed available methods\u0000of removing toxins from the system.</p>","PeriodicalId":21148,"journal":{"name":"Przeglad lekarski","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36044188","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Right-sided aortic arch with aberrant left subclavian artery and hearing loss in patient with abnormal cardiomediastinal contours in routine chest X-ray. 胸片胸膈线异常患者的右侧主动脉弓伴左锁骨下动脉异常及听力丧失。
Pub Date : 2017-01-01
Jerzy Wiliński, Anna Skwarek, Agnieszka Kasprzyk, Bogdan Wiliński, Tomasz Kameczura, Mikołaj Drzysztof Głowacki

Although the development oftechnologically advanced imagingtechniques has progressively reducedthe use of chest X-ray in clinicalpractice, it is still an invaluabletool to evaluate different diseases ofthe respiratory and cardiovascularsystems. We are presenting a caseof a 55-year-old male with arterialhypertension, severe mixed hearingloss who was referred to an internalmedicine ward due to abnormal mediastinaland cardiac contours observedin a routine chest X-ray. Thefinding was linked to an anomalousaortic course what was confirmedwithin transthoracic echocardiography.The computed tomography angiographyof the whole aorta revealedthe right sided aortic arch (RSAA)with four large arteries arising fromthe aortic arch, including the aberrantleft subclavian artery compressingthe esophagus causing thoughno symptoms. Since RSAA might beassociated with other cardiovasculardiseases and genetic disorders including22q11.2 deletion syndrome,we have conducted a complex diagnosticswhich showed additionallya decreased level of lymphocytes.The patient did not consent to geneticdiagnostics and was qualifiedfor conservative treatment of his disorders.In conclusion, a plain chestradiograph with the assessmentof heart silhouette must not be neglectedin cardiologic diagnostics.The identification of even asymptomaticaortic anatomic variant shouldbe followed by the whole aorta angiographyand a detailed assessmentof the patient. RSAA bears potentialrisk of tracheostomy bleeding, unforeseenproblems in transradialcoronary procedures and potentialproblems during thyroid surgery,also because of abnormal recurrentlaryngeal nerves’ course.

尽管先进的成像技术的发展已经逐渐减少了胸部x线在临床实践中的使用,但它仍然是评估不同呼吸系统和心血管系统疾病的宝贵工具。我们报告一例55岁男性动脉高血压,严重混合性听力损失,由于常规胸部x线检查发现纵隔和心脏轮廓异常而被转介到内科病房。这一发现与经胸超声心动图证实的主动脉异常有关。整个主动脉的计算机断层血管造影显示右侧主动脉弓(RSAA),主动脉弓上有四条大动脉,包括异常的左侧锁骨下动脉压迫食道,尽管没有症状。由于RSAA可能与其他心血管疾病和遗传疾病有关,包括22q11.2缺失综合征,我们进行了复杂的诊断,结果显示淋巴细胞水平下降。患者不同意进行基因诊断,有资格对其疾病进行保守治疗。总之,在心脏病诊断中,胸片平片对心脏轮廓的评估是不可忽视的。即使是无症状的主动脉解剖变异,也应该进行全主动脉造影和对患者的详细评估。RSAA具有气管切开出血的潜在风险,在经冠状动脉手术中出现不可预见的问题,在甲状腺手术中出现潜在问题,也因为喉返神经的异常。
{"title":"Right-sided aortic arch with aberrant left subclavian artery and hearing loss in patient with abnormal cardiomediastinal contours in routine chest X-ray.","authors":"Jerzy Wiliński,&nbsp;Anna Skwarek,&nbsp;Agnieszka Kasprzyk,&nbsp;Bogdan Wiliński,&nbsp;Tomasz Kameczura,&nbsp;Mikołaj Drzysztof Głowacki","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Although the development of\u0000technologically advanced imaging\u0000techniques has progressively reduced\u0000the use of chest X-ray in clinical\u0000practice, it is still an invaluable\u0000tool to evaluate different diseases of\u0000the respiratory and cardiovascular\u0000systems. We are presenting a case\u0000of a 55-year-old male with arterial\u0000hypertension, severe mixed hearing\u0000loss who was referred to an internal\u0000medicine ward due to abnormal mediastinal\u0000and cardiac contours observed\u0000in a routine chest X-ray. The\u0000finding was linked to an anomalous\u0000aortic course what was confirmed\u0000within transthoracic echocardiography.\u0000The computed tomography angiography\u0000of the whole aorta revealed\u0000the right sided aortic arch (RSAA)\u0000with four large arteries arising from\u0000the aortic arch, including the aberrant\u0000left subclavian artery compressing\u0000the esophagus causing though\u0000no symptoms. Since RSAA might be\u0000associated with other cardiovascular\u0000diseases and genetic disorders including\u000022q11.2 deletion syndrome,\u0000we have conducted a complex diagnostics\u0000which showed additionally\u0000a decreased level of lymphocytes.\u0000The patient did not consent to genetic\u0000diagnostics and was qualified\u0000for conservative treatment of his disorders.\u0000In conclusion, a plain chest\u0000radiograph with the assessment\u0000of heart silhouette must not be neglected\u0000in cardiologic diagnostics.\u0000The identification of even asymptomatic\u0000aortic anatomic variant should\u0000be followed by the whole aorta angiography\u0000and a detailed assessment\u0000of the patient. RSAA bears potential\u0000risk of tracheostomy bleeding, unforeseen\u0000problems in transradial\u0000coronary procedures and potential\u0000problems during thyroid surgery,\u0000also because of abnormal recurrent\u0000laryngeal nerves’ course.</p>","PeriodicalId":21148,"journal":{"name":"Przeglad lekarski","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36044190","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Hypoglycemia due to antibodies to exogenous insulin in a patient with type 2 diabetes – a case report of treatment with new generation oral hypoglycemic agents]. [1例2型糖尿病患者外源性胰岛素抗体所致低血糖-新一代口服降糖药治疗1例报告]。
Pub Date : 2017-01-01
Damian Ucieklak, Joanna Zięba-Parkitny, Elżbieta Kozek, Jan Skupień, Krystyna Sztefko, Maciej T Małecki

Hypoglycemic syndromes associatedwith immune reactions againstinsulin are rare phenomena describedpredominantly in Asians. Steroidtherapy, immunosuppression or plasmapheresisis often required.

Case report: A 73-year-old Whitewoman with a 20-year history of type2 diabetes was admitted to hospitaldue to recurrent incidents of hypoglycemiathat started several monthsafter insulin initiation (lispro 75/25)and increased in severity over thenext 5 years. They were accompaniedby postprandial hyperglycemia upto 25 mmol/l. The patient’s glycatedhemoglobin (HbA1c) was 70 mmol/mol (8.6%). During hypoglycemicepisodes recorded serum C-peptidewas 0.57-0.73 nmol/l (1.7-2.2 ng/ml),while insulin concentration exceeded7000 pmol/l (1000 mIU/l). Surreptitiousinsulin administration was ruled out aswas, based on diagnostic imaging, thepresence of an insulin secreting tumor.Anti-insulin antibody (AIA) level measuredby 125I-insulin binding method was92.5% (normal < 8.2%). Hypoglycemicepisodes occurred for four days afterdiscontinuation of insulin therapyand then resolved completely. Goodglycemic control was maintained withmetformin, acarbose and dapagliflozin.Three months later dapagliflozin wasreplaced with vildagliptine due to poortolerance of a SGLT-2 inhibitor. Patient’sHbA1c was 54 mmol/mol (7.1%),total fasting insulin level 2577 pmol/land AIA binding 85.9%. Over the nextyear the patient has not experiencedhypoglycemia and maintained goodglycemic control, as HbA1c level was 53mmol/l (7.0%) and AIA binding 39.5%.

Conclusions: In this rare case ofa patient with diabetes and hypoglycemicsyndrome related to AIA, weachieved a rapid and stable remissionof hypoglycemia without immunosuppression.Good glycemic control, despite 20-year historyof diabetes was achieved with oral hypoglycemic agents.

与胰岛素免疫反应相关的低血糖综合征是一种罕见的现象,主要发生在亚洲。通常需要类固醇治疗、免疫抑制或血浆清除。病例报告:一名73岁白人女性,有20年2型糖尿病病史,因胰岛素治疗数月后低血糖复发入院(lispro 75/25),并在接下来的5年中病情加重。伴餐后高血糖,最高可达25 mmol/l。患者糖化血红蛋白(HbA1c) 70 mmol/mol(8.6%)。低血糖发作时记录的血清c肽为0.57 ~ 0.73 nmol/l (1.7 ~ 2.2 ng/ml),而胰岛素浓度超过7000 pmol/l (1000 mIU/l)。根据诊断成像,排除了偷偷使用胰岛素的可能性,因为存在胰岛素分泌性肿瘤。125i -胰岛素结合法测定抗胰岛素抗体(AIA)水平为92.5%(正常< 8.2%)。停止胰岛素治疗后4天出现低血糖发作,然后完全消退。使用二甲双胍、阿卡波糖和达格列净维持良好的血糖控制。3个月后,由于SGLT-2抑制剂耐受性差,达格列净被维格列汀取代。患者shba1c为54 mmol/mol(7.1%),总空腹胰岛素水平2577 pmol/陆地AIA结合85.9%。在接下来的一年中,患者没有发生低血糖,血糖控制良好,HbA1c水平为53mmol/l (7.0%), AIA结合39.5%。结论:在这例罕见的糖尿病合并AIA相关低血糖综合征患者中,我们在没有免疫抑制的情况下实现了快速稳定的低血糖缓解。尽管有20年的糖尿病病史,口服降糖药仍能控制良好的血糖。
{"title":"[Hypoglycemia due to antibodies to exogenous insulin in a patient with type 2 diabetes – a case report of treatment with new generation oral hypoglycemic agents].","authors":"Damian Ucieklak,&nbsp;Joanna Zięba-Parkitny,&nbsp;Elżbieta Kozek,&nbsp;Jan Skupień,&nbsp;Krystyna Sztefko,&nbsp;Maciej T Małecki","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Hypoglycemic syndromes associated\u0000with immune reactions against\u0000insulin are rare phenomena described\u0000predominantly in Asians. Steroid\u0000therapy, immunosuppression or plasmapheresis\u0000is often required.</p><p><strong>Case report: </strong>A 73-year-old White\u0000woman with a 20-year history of type\u00002 diabetes was admitted to hospital\u0000due to recurrent incidents of hypoglycemia\u0000that started several months\u0000after insulin initiation (lispro 75/25)\u0000and increased in severity over the\u0000next 5 years. They were accompanied\u0000by postprandial hyperglycemia up\u0000to 25 mmol/l. The patient’s glycated\u0000hemoglobin (HbA1c) was 70 mmol/\u0000mol (8.6%). During hypoglycemic\u0000episodes recorded serum C-peptide\u0000was 0.57-0.73 nmol/l (1.7-2.2 ng/ml),\u0000while insulin concentration exceeded\u00007000 pmol/l (1000 mIU/l). Surreptitious\u0000insulin administration was ruled out as\u0000was, based on diagnostic imaging, the\u0000presence of an insulin secreting tumor.\u0000Anti-insulin antibody (AIA) level measured\u0000by 125I-insulin binding method was\u000092.5% (normal < 8.2%). Hypoglycemic\u0000episodes occurred for four days after\u0000discontinuation of insulin therapy\u0000and then resolved completely. Good\u0000glycemic control was maintained with\u0000metformin, acarbose and dapagliflozin.\u0000Three months later dapagliflozin was\u0000replaced with vildagliptine due to poor\u0000tolerance of a SGLT-2 inhibitor. Patient’s\u0000HbA1c was 54 mmol/mol (7.1%),\u0000total fasting insulin level 2577 pmol/l\u0000and AIA binding 85.9%. Over the next\u0000year the patient has not experienced\u0000hypoglycemia and maintained good\u0000glycemic control, as HbA1c level was 53\u0000mmol/l (7.0%) and AIA binding 39.5%.</p><p><strong>Conclusions: </strong>In this rare case of\u0000a patient with diabetes and hypoglycemic\u0000syndrome related to AIA, we\u0000achieved a rapid and stable remission\u0000of hypoglycemia without immunosuppression.\u0000Good glycemic control, despite 20-year history\u0000of diabetes was achieved with oral hypoglycemic agents.</p>","PeriodicalId":21148,"journal":{"name":"Przeglad lekarski","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36041723","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Minimally invasive direct coronary artery bypass (MIDCAB) – safety assessment in own material. 微创直接冠状动脉搭桥术(MIDCAB) -自身材料的安全性评估。
Pub Date : 2017-01-01
Jacek Piątek, Janusz Konstanty-Kalandyk, Anna Kędziora, Bryan Hyochan Song, Karol Wierzbicki, Tomasz Darocha, Dorota Sobczyk, Bogusław Kapelak

Introduction: Minimally invasivedirect coronary artery bypass (MIDCAB)allows achieving similar safetyand efficacy, with markedly reducedpost-operative length of stay whencompared to conventional surgicalrevascularization. Despite promisingresults, a small number of minimallyinvasive procedures are performed inPoland. The aim of the study is to assessshort- and long-term outcome ofMIDCAB revascularization in order toevaluate the safety of the procedure.

Materials and methods: Retrospectiveobservational study analyzing 38consecutive patients who underwentMIDCAB procedure between 2014 to2016 in the Department of CardiovascularSurgery and Transplantologyat the John Paul II Hospital, Kraków.Perioperative data was obtained frompatient medical records and the medianfollow-up period valued 17.3months.

Results: No postoperative deathsand only 1 case of postoperativemyocardial infarction were observed.Throughout the follow-up period, thesurvival rate and freedom from MACCErate valued 100%, with only 1 caseof repeated revascularization.

Conclusions: Minimally invasiverevascularization is a safe procedurewhich can be performed with excellentshort- and long-term outcome inlow-risk patients.

微创直接冠状动脉搭桥术(MIDCAB)与传统手术血运重建术相比,具有相似的安全性和有效性,且术后住院时间明显缩短。尽管结果很有希望,但在波兰进行了少量微创手术。该研究的目的是评估midcab血运重建术的短期和长期结果,以评估该手术的安全性。材料和方法:回顾性观察研究分析了2014年至2016年期间在约翰保罗二世医院心血管外科和移植科接受midcab手术的38例连续患者,Kraków。围手术期资料来源于患者病历,中位随访期17.3个月。结果:无术后死亡病例,术后心肌梗死1例。在整个随访期间,MACCErate的存活率和自由度为100%,只有1例反复血运重建术。结论:微创血管成形术是一种安全的手术,对低危患者具有良好的短期和长期预后。
{"title":"Minimally invasive direct coronary artery bypass (MIDCAB) – safety assessment in own material.","authors":"Jacek Piątek,&nbsp;Janusz Konstanty-Kalandyk,&nbsp;Anna Kędziora,&nbsp;Bryan Hyochan Song,&nbsp;Karol Wierzbicki,&nbsp;Tomasz Darocha,&nbsp;Dorota Sobczyk,&nbsp;Bogusław Kapelak","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>Minimally invasive\u0000direct coronary artery bypass (MIDCAB)\u0000allows achieving similar safety\u0000and efficacy, with markedly reduced\u0000post-operative length of stay when\u0000compared to conventional surgical\u0000revascularization. Despite promising\u0000results, a small number of minimally\u0000invasive procedures are performed in\u0000Poland. The aim of the study is to assess\u0000short- and long-term outcome of\u0000MIDCAB revascularization in order to\u0000evaluate the safety of the procedure.</p><p><strong>Materials and methods: </strong>Retrospective\u0000observational study analyzing 38\u0000consecutive patients who underwent\u0000MIDCAB procedure between 2014 to\u00002016 in the Department of Cardiovascular\u0000Surgery and Transplantology\u0000at the John Paul II Hospital, Kraków.\u0000Perioperative data was obtained from\u0000patient medical records and the median\u0000follow-up period valued 17.3\u0000months.</p><p><strong>Results: </strong>No postoperative deaths\u0000and only 1 case of postoperative\u0000myocardial infarction were observed.\u0000Throughout the follow-up period, the\u0000survival rate and freedom from MACCE\u0000rate valued 100%, with only 1 case\u0000of repeated revascularization.</p><p><strong>Conclusions: </strong>Minimally invasive\u0000revascularization is a safe procedure\u0000which can be performed with excellent\u0000short- and long-term outcome in\u0000low-risk patients.</p>","PeriodicalId":21148,"journal":{"name":"Przeglad lekarski","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36041728","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Analysis of histological type and staging of cervical cancer as prognostic factors among women treated in the Department of Gynecology and Oncology, Jagiellonian University in the years 2001-2014]. [2001-2014年雅盖隆大学妇科肿瘤科治疗女性宫颈癌的组织学分型及分期作为预后因素分析]。
Pub Date : 2017-01-01
Tomasz Basta, Iwona Gawron, Krzysztof Mirocki, Dorota Babczyk, Robert Jach

Introduction: Cervical cancer (CC)is the fourth most common, in termsof incidence of new cases, cancer inwomen and the third leading cause ofcancer deaths in women worldwide.Survival of patients with CC dependson many factors, including the typeof cancer, grading, FIGO staging andtreatment.

Material and methods: Analysis of survival of 524 patients diagnosedwith invasive and non-invasive CC dependingon histopathologic diagnosis,clinical staging, tumor grading andcombination of therapy.

Results: The 2-fold increase in therisk of death at diagnosis in order ofHSIL> ca planoepitheliale> adenocarcinoma>sarcoma was noted. Grading2 and 3 significantly reduces the averagesurvival in patients diagnosed withCC. The higher staging, the shorter theaverage survival. Each pass by oneFIGO stage was shown to increasethe risk of death by 46%. The risk ofdeath increases by 4% with every yearof woman’s life. The longest averagesurvival, 72 months, characterized agroup of women undergoing curettage,followed by radical hysterectomy/trachelectomy and lymphadenectomywithout adiuvant radio-/ chemotherapy.The shortest survival, 26.9 months,was observed in the group treated withcurettage followed by chemoradiation.

Conclusions: Histopathology, clinical staging, grading, age andcombination of treatment proved to besignificant factors affecting survival inwomen with CC.

引言:就新发病例发生率而言,宫颈癌(CC)是第四大最常见的女性癌症,也是全球女性癌症死亡的第三大原因。CC患者的生存取决于许多因素,包括癌症类型、分级、FIGO分期和治疗。材料与方法:根据组织病理学诊断、临床分期、肿瘤分级及联合治疗对524例浸润性和非浸润性CC患者的生存进行分析。结果:hsil >扁平上皮癌>腺癌>肉瘤,诊断时死亡风险增加2倍。2级和3级显著降低诊断为cc的患者的平均生存率。分期越高,平均生存期越短。每过一个figo阶段,死亡风险增加46%。妇女寿命每延长一年,死亡风险增加4%。最长的平均生存期为72个月,特征组为行刮除术,随后行根治性子宫切除术/气管切除术和淋巴结切除术,无辅助放疗/化疗。刮除后放化疗组的生存期最短,为26.9个月。结论:组织病理学、临床分期、分级、年龄和联合治疗是影响女性CC患者生存的重要因素。
{"title":"[Analysis of histological type and staging of cervical cancer as prognostic factors among women treated in the Department of Gynecology and Oncology, Jagiellonian University in the years 2001-2014].","authors":"Tomasz Basta,&nbsp;Iwona Gawron,&nbsp;Krzysztof Mirocki,&nbsp;Dorota Babczyk,&nbsp;Robert Jach","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>Cervical cancer (CC)\u0000is the fourth most common, in terms\u0000of incidence of new cases, cancer in\u0000women and the third leading cause of\u0000cancer deaths in women worldwide.\u0000Survival of patients with CC depends\u0000on many factors, including the type\u0000of cancer, grading, FIGO staging and\u0000treatment.</p><p><strong>Material and methods: </strong>Analysis of survival of 524 patients diagnosed\u0000with invasive and non-invasive CC depending\u0000on histopathologic diagnosis,\u0000clinical staging, tumor grading and\u0000combination of therapy.</p><p><strong>Results: </strong>The 2-fold increase in the\u0000risk of death at diagnosis in order of\u0000HSIL> ca planoepitheliale> adenocarcinoma>\u0000sarcoma was noted. Grading\u00002 and 3 significantly reduces the average\u0000survival in patients diagnosed with\u0000CC. The higher staging, the shorter the\u0000average survival. Each pass by one\u0000FIGO stage was shown to increase\u0000the risk of death by 46%. The risk of\u0000death increases by 4% with every year\u0000of woman’s life. The longest average\u0000survival, 72 months, characterized a\u0000group of women undergoing curettage,\u0000followed by radical hysterectomy/\u0000trachelectomy and lymphadenectomy\u0000without adiuvant radio-/ chemotherapy.\u0000The shortest survival, 26.9 months,\u0000was observed in the group treated with\u0000curettage followed by chemoradiation.</p><p><strong>Conclusions: </strong>Histopathology, clinical staging, grading, age and\u0000combination of treatment proved to be\u0000significant factors affecting survival in\u0000women with CC.</p>","PeriodicalId":21148,"journal":{"name":"Przeglad lekarski","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36042808","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anemia in diabetic kidney disease - underappreciated but still clinically relevant problem. 糖尿病肾病中的贫血——未被重视但仍与临床相关的问题。
Pub Date : 2017-01-01
Agnieszka Zapora-Kurel, Marta Rydzewska, Maciej Edward Małyszko, Adrianna Zajkowska, Natalia Anna Drobek, Jolanta Małyszko

Anemia is the most common disorderof the blood with iron deficiencybeing the predominant cause. On theother hand, diabetes prevalence isincreasing rapidly. Over time, diabetescan damage the heart, bloodvessels, eyes, kidneys, and nerves.Diabetic kidney disease (DKD) maybe present in both types 1 and type2 diabetes mellitus. Anemia is one ofthe common feature of chronic kidneydisease. The epidemiological data onanemia prevalence are limited. In thisreview data on epidemiology, pathogenesis,complication and treatmentof anemia in diabetic kidney diseaseare presented.

贫血是最常见的血液疾病,缺铁是主要原因。另一方面,糖尿病患病率正在迅速上升。随着时间的推移,糖尿病会损害心脏、血管、眼睛、肾脏和神经。糖尿病肾病(DKD)可能存在于1型和2型糖尿病。贫血是慢性肾脏疾病的共同特征之一。关于贫血患病率的流行病学数据有限。本文就糖尿病肾病贫血的流行病学、发病机制、并发症及治疗进行综述。
{"title":"Anemia in diabetic kidney disease - underappreciated but still clinically relevant problem.","authors":"Agnieszka Zapora-Kurel,&nbsp;Marta Rydzewska,&nbsp;Maciej Edward Małyszko,&nbsp;Adrianna Zajkowska,&nbsp;Natalia Anna Drobek,&nbsp;Jolanta Małyszko","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Anemia is the most common disorder\u0000of the blood with iron deficiency\u0000being the predominant cause. On the\u0000other hand, diabetes prevalence is\u0000increasing rapidly. Over time, diabetes\u0000can damage the heart, blood\u0000vessels, eyes, kidneys, and nerves.\u0000Diabetic kidney disease (DKD) may\u0000be present in both types 1 and type\u00002 diabetes mellitus. Anemia is one of\u0000the common feature of chronic kidney\u0000disease. The epidemiological data on\u0000anemia prevalence are limited. In this\u0000review data on epidemiology, pathogenesis,\u0000complication and treatment\u0000of anemia in diabetic kidney disease\u0000are presented.</p>","PeriodicalId":21148,"journal":{"name":"Przeglad lekarski","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36044338","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Endometrial cancer and hyperplasia rate in women before menopause with abnormal uterine bleeding undergoing endometrial sampling. 绝经前子宫异常出血妇女子宫内膜取样中子宫内膜癌和增生的发生率。
Pub Date : 2017-01-01
Iwona Gawron, Magdalena Łoboda, Dorota Babczyk, Inga Ludwin, Paweł Basta, Kazimierz Pityński, Artur Ludwin

Introduction: Abnormal uterinebleeding (AUB) is the most commonsymptom of endometrial cancer (EC)and endometrial hyperplasia with(AH) or without (EH) atypia. Risk ofmalignancy and hyperplasia is significantlylower in premenopausalthan in postmenopausal women. Only10% of EC occurs before menopause.Obesity and age are well-recognizedrisk factors of endometrial cancer.Endometrial sampling is recommendedin women at high risk of endometrialmalignancy. The primary objectivewas to determine the incidenceof EC, AH and EH in premenopausalwomen undergoing dilation and curettage(D&C) because of AUB. Additionalobjective of the study wasto estimate the risk of EC and AH inoverweight and obese women withtwo types of AUB: heavy menstrualbleeding (AUB-HMB) and intermenstrualbleeding (AUB-IMB), accordingto PALM-COEIN classification.

Material and methods: Retrospectivestudy in the population of womenundergoing D&C in tertiary hospitalbecause of AUB between Jan-2016and Dec-2016. The incidence of EC,AH, EH was established. The influenceof the variables: age, BMI, AUBHMB/AUB-IMB on the occurrence ofabnormal histology (EC, AH, EH) wasevaluated. Finally, the model built byusing backward stepwise regressionand mechanism of v-fold cross-validation,showed no statistically significantrelationship.

Results: EC was detected in 2/213cases (0.9%; 95% CI 0.0003 to 0.036),AH in 3/213 cases (1.4%), giving a totalof 5/213 (2.3%) women with AH orEC. EH was detected in 16/213 (7.5%)women. High BMI raises the chance ofAH diagnosis: OR 1.16 (95% CI 1.05-1.28). The presence of HMB comparedto IMB reduces the chance of EH: OR0.24 (95% CI 0.07-0.9). IMB increasesthe chance for the diagnosis of EH 4.11 times compared toHMB (OR 4.1, 95% CI 1.1-14.9; p = 0.016).

Conclusions: EC in premenopausal women with AUBundergoing D&C is rare. There is a need to search formore effective methods of selection of patients than commonlyused. Age and BMI do not seem to be factors thatshould be used to select patients.

异常子宫出血(AUB)是子宫内膜癌(EC)和子宫内膜增生伴AH或不伴EH异型的最常见症状。绝经前妇女患恶性肿瘤和增生的风险明显低于绝经后妇女。只有10%的乳腺癌发生在绝经前。肥胖和年龄是公认的子宫内膜癌的危险因素。子宫内膜取样是建议子宫内膜恶性肿瘤高风险的妇女。主要目的是确定因AUB而行扩张刮除术(D&C)的绝经前妇女EC、AH和EH的发生率。该研究的另一个目的是根据PALM-COEIN分类,估计有两种AUB类型的超重和肥胖女性发生EC和AH的风险:重度月经出血(AUB- hmb)和月经间出血(AUB- imb)。材料与方法:对2016年1月至2016年12月因AUB在三级医院行D&C的女性进行回顾性研究。确定了EC、AH、EH的发病率。评估年龄、BMI、AUBHMB/AUB-IMB对异常组织学(EC、AH、EH)发生的影响。最后,通过反向逐步回归和v-fold交叉验证机制建立的模型没有统计学意义的关系。结果:2/213例中检出EC (0.9%;95% CI 0.0003 ~ 0.036), 3/213例AH(1.4%),总共5/213例(2.3%)女性患有AH orEC。213名妇女中有16名(7.5%)检出EH。高BMI增加ah诊断的机会:OR 1.16 (95% CI 1.05-1.28)。与IMB相比,HMB的存在降低了EH的机会:OR0.24 (95% CI 0.07-0.9)。与hmb相比,IMB使EH的诊断机会增加4.11倍(OR 4.1, 95% CI 1.1-14.9;P = 0.016)。结论:绝经前aub行D&C的妇女发生EC是罕见的。有必要寻找比常用的更有效的患者选择方法。年龄和体重指数似乎不应该作为选择患者的因素。
{"title":"Endometrial cancer and hyperplasia rate in women before menopause with abnormal uterine bleeding undergoing endometrial sampling.","authors":"Iwona Gawron,&nbsp;Magdalena Łoboda,&nbsp;Dorota Babczyk,&nbsp;Inga Ludwin,&nbsp;Paweł Basta,&nbsp;Kazimierz Pityński,&nbsp;Artur Ludwin","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>Abnormal uterine\u0000bleeding (AUB) is the most common\u0000symptom of endometrial cancer (EC)\u0000and endometrial hyperplasia with\u0000(AH) or without (EH) atypia. Risk of\u0000malignancy and hyperplasia is significantly\u0000lower in premenopausal\u0000than in postmenopausal women. Only\u000010% of EC occurs before menopause.\u0000Obesity and age are well-recognized\u0000risk factors of endometrial cancer.\u0000Endometrial sampling is recommended\u0000in women at high risk of endometrial\u0000malignancy. The primary objective\u0000was to determine the incidence\u0000of EC, AH and EH in premenopausal\u0000women undergoing dilation and curettage\u0000(D&C) because of AUB. Additional\u0000objective of the study was\u0000to estimate the risk of EC and AH in\u0000overweight and obese women with\u0000two types of AUB: heavy menstrual\u0000bleeding (AUB-HMB) and intermenstrual\u0000bleeding (AUB-IMB), according\u0000to PALM-COEIN classification.</p><p><strong>Material and methods: </strong>Retrospective\u0000study in the population of women\u0000undergoing D&C in tertiary hospital\u0000because of AUB between Jan-2016\u0000and Dec-2016. The incidence of EC,\u0000AH, EH was established. The influence\u0000of the variables: age, BMI, AUBHMB/\u0000AUB-IMB on the occurrence of\u0000abnormal histology (EC, AH, EH) was\u0000evaluated. Finally, the model built by\u0000using backward stepwise regression\u0000and mechanism of v-fold cross-validation,\u0000showed no statistically significant\u0000relationship.</p><p><strong>Results: </strong>EC was detected in 2/213\u0000cases (0.9%; 95% CI 0.0003 to 0.036),\u0000AH in 3/213 cases (1.4%), giving a total\u0000of 5/213 (2.3%) women with AH or\u0000EC. EH was detected in 16/213 (7.5%)\u0000women. High BMI raises the chance of\u0000AH diagnosis: OR 1.16 (95% CI 1.05-\u00001.28). The presence of HMB compared\u0000to IMB reduces the chance of EH: OR\u00000.24 (95% CI 0.07-0.9). IMB increases\u0000the chance for the diagnosis of EH 4.11 times compared to\u0000HMB (OR 4.1, 95% CI 1.1-14.9; p = 0.016).</p><p><strong>Conclusions: </strong>EC in premenopausal women with AUB\u0000undergoing D&C is rare. There is a need to search for\u0000more effective methods of selection of patients than commonly\u0000used. Age and BMI do not seem to be factors that\u0000should be used to select patients.</p>","PeriodicalId":21148,"journal":{"name":"Przeglad lekarski","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36044568","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Membranous nephropathy - the most commonly diagnosed glomerulopathy in patients who underwent renal biopsy in the Department of Internal Medicine, Nephrology and Endocrinology St. Queen Jadwiga Clinical District Hospital No. 2 in Rzeszow]. 【膜性肾病——在Rzeszow的St. Queen Jadwiga临床区医院第二内科、肾脏病学和内分泌科接受肾活检的患者中最常见的肾小球病变】。
Pub Date : 2017-01-01
Aneta Kołodziej-Kłęk, Agnieszka Gala-Błądzińska, Krzysztof Okoń, Agnieszka Sadowska, Grzegorz Świder

We retrospectively analysedthe results of 120 renal biopsy, performedin 52 women, 62 men and 6children hospitalized mainly in theDepartment of Internal Medicine,Nephrology and Endocrinology St.Queen Jadwiga Clinical District HospitalNo. 2 in Rzeszów from 2013 to2016. The average age of patients onwhom renal biopsy was performedamounts to 44 (7-78) years. The mostcommon indications for renal biopsywere nephrotic syndrome in 47 patients(37.3%), non-nephrotic proteinuriain 31 patients (24.6%), worseningrenal function in 22 patients(17.5%), coexistence proteinuria withhematuria in 16 patients (12.7%), nephriticsyndrome in 9 patients (7.1%)as well as an isolated hematuria in 1patient (0.8%). Membranous glomerulonephritiswas the most commonhistological diagnosis observed inbiopsies, and was diagnosed in 19patients (15.1%). In 14 patients wediagnosed lupus nephritis (11.1%).With the same frequency we diagnosedfocal glomerulosclerosis, andmesangioproliferative glomerulonephritis(11 patients, 8,7%). Membraneproliferativeglomerulonephritis wasdiagnosed in 10 patients (7.9%).Other nephropathy accounted forless than 8% of all diagnoses. Mostpatients with membranous nephropathy(8 patients, 61%) had antibodiesagainst phospholipase A2 receptor.All patients with a diagnosis of membranousnephropathy received the renin-angiotensin-aldosterone systemblockade, and 13 patients (68.4%) receivedimmunosuppressive therapy.Complete remission was achieved in 11 patients (64.7%)with primary membranous nephropathy. In 35 patients(27.8%) of all patients who underwent renal biopsy theyhad complications after procedure in the form of small andclinically insignificant perirenal hematomas. Hematuriawas observed in 7 cases (5.56%). In one case, due to retroperitonealbleeding, the patient required a transfusion ofblood products.

我们回顾性分析了主要在St.Queen Jadwiga临床区医院内科、肾脏病学和内分泌科住院的52例女性、62例男性和6例儿童进行的120例肾活检的结果。2 .从2013年到2016年在Rzeszów。肾活检患者的平均年龄为44岁(7-78岁)。肾活检最常见的适应症为肾病综合征47例(37.3%),非肾病性蛋白尿31例(24.6%),肾功能恶化22例(17.5%),蛋白尿合并血尿16例(12.7%),肾病综合征9例(7.1%),单纯性血尿1例(0.8%)。膜性肾小球肾炎是活检中最常见的组织学诊断,确诊19例(15.1%)。14例患者被诊断为狼疮性肾炎(11.1%)。我们诊断局灶性肾小球硬化和系血管增殖性肾小球肾炎的频率相同(11例,8.7%)。10例(7.9%)诊断为膜增生性肾小球肾炎。其他肾病占所有诊断的不到8%。大多数膜性肾病患者(8例,61%)存在针对磷脂酶A2受体的抗体。所有诊断为膜性肾病的患者均接受肾素-血管紧张素-醛固酮系统阻断治疗,13例患者(68.4%)接受免疫抑制治疗。11例(64.7%)原发性膜性肾病患者获得完全缓解。在所有接受肾活检的患者中,有35例(27.8%)患者在手术后出现临床不明显的小肾周血肿并发症。血尿7例(5.56%)。在一个病例中,由于腹膜后出血,患者需要输血。
{"title":"[Membranous nephropathy - the most commonly diagnosed glomerulopathy in patients who underwent renal biopsy in the Department of Internal Medicine, Nephrology and Endocrinology St. Queen Jadwiga Clinical District Hospital No. 2 in Rzeszow].","authors":"Aneta Kołodziej-Kłęk,&nbsp;Agnieszka Gala-Błądzińska,&nbsp;Krzysztof Okoń,&nbsp;Agnieszka Sadowska,&nbsp;Grzegorz Świder","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>We retrospectively analysed\u0000the results of 120 renal biopsy, performed\u0000in 52 women, 62 men and 6\u0000children hospitalized mainly in the\u0000Department of Internal Medicine,\u0000Nephrology and Endocrinology St.\u0000Queen Jadwiga Clinical District Hospital\u0000No. 2 in Rzeszów from 2013 to\u00002016. The average age of patients on\u0000whom renal biopsy was performed\u0000amounts to 44 (7-78) years. The most\u0000common indications for renal biopsy\u0000were nephrotic syndrome in 47 patients\u0000(37.3%), non-nephrotic proteinuria\u0000in 31 patients (24.6%), worsening\u0000renal function in 22 patients\u0000(17.5%), coexistence proteinuria with\u0000hematuria in 16 patients (12.7%), nephritic\u0000syndrome in 9 patients (7.1%)\u0000as well as an isolated hematuria in 1\u0000patient (0.8%). Membranous glomerulonephritis\u0000was the most common\u0000histological diagnosis observed in\u0000biopsies, and was diagnosed in 19\u0000patients (15.1%). In 14 patients we\u0000diagnosed lupus nephritis (11.1%).\u0000With the same frequency we diagnosed\u0000focal glomerulosclerosis, and\u0000mesangioproliferative glomerulonephritis\u0000(11 patients, 8,7%). Membraneproliferative\u0000glomerulonephritis was\u0000diagnosed in 10 patients (7.9%).\u0000Other nephropathy accounted for\u0000less than 8% of all diagnoses. Most\u0000patients with membranous nephropathy\u0000(8 patients, 61%) had antibodies\u0000against phospholipase A2 receptor.\u0000All patients with a diagnosis of membranous\u0000nephropathy received the renin-\u0000angiotensin-aldosterone system\u0000blockade, and 13 patients (68.4%) received\u0000immunosuppressive therapy.\u0000Complete remission was achieved in 11 patients (64.7%)\u0000with primary membranous nephropathy. In 35 patients\u0000(27.8%) of all patients who underwent renal biopsy they\u0000had complications after procedure in the form of small and\u0000clinically insignificant perirenal hematomas. Hematuria\u0000was observed in 7 cases (5.56%). In one case, due to retroperitoneal\u0000bleeding, the patient required a transfusion of\u0000blood products.</p>","PeriodicalId":21148,"journal":{"name":"Przeglad lekarski","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36045761","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Przeglad lekarski
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1